Sanyou Bio Secures Exclusive Series C Investment from Zero2IPO Industry Investment, Bringing Total Funding to Nearly RMB 300 Million
- Written by PR Newswire
Accelerating the Development of an AI-Driven Ecosystem for Innovative Drug R&D and Translation
SHANGHAI, Nov. 9, 2026 /PRNewswire/ -- Sanyou Biopharmaceuticals Co., Ltd. ("Sanyou Bio") recently announced the completion of a Series C financing round worth nearly RMB 100 million. The round was exclusively funded by Zero2IPO Industry Investment, a...













